Sensex jumps 250 pts; pharma & IT stocks rally, Divis Labs zooms

Divis Laboratories Update by Epic Research
Divis Labs surged more than 15 percent intraday as the US Food & Drug Administration will lift import alert 99-32 on the company’s unit-II at Visakhapatnam.

The USFDA had issued an Import Alert under clauses 99-32 and 66-40 in March of 2017 and a warning letter in May of 2017 for Vishakhapatnam facility.

Divi’s Laboratories had filed a detailed responses and given updates to the Form-483 and the warning letter within the stipulated time.

For more information & more Stocks to buy today.

Call us ✆ – 0731-6642300 or


Connect with our social media sites
Next Post »